Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Interim Report Third Quarter 2019

FluoGuide A/S ("FluoGuide") today announces its results for the period 01/July/2019 – 30/Sep/2019. The full report is available on the company’s homepage.(Correction as PDF was not attached due to technical reasons) Morten Albrechtsen, CEO of FluoGuide, comments: “We are very pleased that the supply chain for FG001 has been established to support the first clinical study in humans and the process for FG001 manufacturing was successfully transferred to vendors who can make it to a quality needed for human use. This is good news and a major de-risking for a positive proof-of-concept

Interim report January - September 2019

QUARTER 3             · Revenue increased by 46% to SEK 437 million (301). · EBITDA before items affecting comparability increased by 105% to SEK 62 million (30) with a margin of 14.1% (10.0%).  · EBITDA after items affecting comparability increased by 102% to SEK 59 million (29) with a margin of 13.4% (9.7%). · Operating profit increased by 133% to SEK 38 million (16) with a margin of 8.8% (5.5%). · Net income increased by 181% to SEK 20 million (7).  · Earnings per share, basic and diluted, equalled SEK 9.5 (5.3). YEAR-TO-DATE  · Revenue increased by 90% to SEK

YIT signs a contract on the construction of Lauritsala school with the life cycle model

YIT Corporation Investor News November 29, 2019 at 10:00 a.m.YIT and the City of Lappeenranta have signed a contract on the construction and maintenance of Lauritsala school. YIT is responsible for the design, realisation and 20-year service period of the project carried out in accordance with the life cycle model. The total value of the project is approximately EUR 32 million. The contract will be entered in the order backlog for the fourth quarter of 2019.  The new Lauritsala school will be built to replace the old school building that was demolished in 2016. It will respond to the

Jefast Holding AB (publ) publishes its Quarterly report For the Period Jan- September 2019

Please see a summary of the highlights from the quarterly report below as well as the full report attached to this pressrelease, which is also available on our website: www.jefast.sePeriod July-September 2019  · Revenue amounted to 56.4 m (62.1) · Operating profit amounted to -6.6 m (12.6) Period Jan – September 2019 · Revenue increased to 230.9 m (240.3) · Operating profit amounted to -14.8 m (70.3) · Net Loan to Value amounted to 61.5% (66.3) · The interest coverage ratio amounted to 1.3 (1.4) · Property value of 2,548 m (3,324) Events in the reporting

Rejlers wins contract for major railway project in Finland

Rejlers has signed a contract with the Finnish Transport Infrastructure Agency (FTIA) for the improvement of the Kouvola–Kotka/Hamina railway, one of the most important cargo railway lines in Finland. Rejlers will provide services related to the construction contracting, supervision and design of the railway project.The Kouvola–Kotka/Hamina stretch is one of the most important, if not the most important, cargo railway lines in Finland. - There has been much discussion of the health and competitiveness of the Finnish export industry. The ports of Hamina and Kotka are important to Finland,

Caverion Corporation - Managers' transactions - Bisectra S.A.

Caverion Corporation Stock exchange release 29 November 2019 at 9.50 a.m. EETCaverion Corporation - Managers' transactions - Bisectra S.A. Person subject to the notification requirement Name: Bisectra S.A. Position: Closely associated person (X) Legal person (1):Person Discharging Managerial Responsibilities In Issuer Name: Ehrnrooth, Markus Position: Member of the Board Issuer: Caverion Oyj LEI: 7437007ECQWVPCJIS695 Notification type: INITIAL NOTIFICATION Reference number: 7437007ECQWVPCJIS695_20191127180302_5 ____________________________________________

Photocure to present at Nordic-American Life Science Conference in New York

Oslo, Norway, November 29, 2019 - Photocure ASA (OSE: PHO) will be presenting at the Nordic-American Life Science Conference in New York on December 5.The presentation is scheduled at 8:30am EDT and will be held by Dan Schneider, President and CEO of Photocure ASA. The presentation will be posted on www.photocure.com when held on December 5. Company contact:Erik DahlChief Financial OfficerTel: +47 450 55 000Email: ed@photocure.com About Photocure ASAPhotocure, The Bladder Cancer Company, delivers transformative solutions to improve the lives of bladder cancer patients. Our

Interim report Q3 2019

OmniCar Holding AB publishes the Q3 2019 interim report· Q3 Revenue totalled SEK 4.508 thousand · Q3 profit after financial income and expenses, net amounted to SEK 594 thousand · Q3 earnings per share* is SEK 0.03 for the quarter Together with this report, we have released a video where we explain more about our strategy going forward – You can find the video on our Facebook site and on our investor site www.omnicar.com/investor-relations/ We expect the positive trends and results from Q3 2019 be reflected into Q4 2019 and in 2020.

Notification according to Chapter 9, Section 10 of the Finnish Securities Markets Act of change in holdings in Caverion Corporation shares: Fennogens Investments S.A.

Caverion Corporation Stock exchange release 29 November 2019 at 9.35 a.m. EETNotification according to Chapter 9, Section 10 of the Finnish Securities Markets Act of change in holdings in Caverion Corporation shares: Fennogens Investments S.A.  Caverion Corporation has on 28 November 2019 received a notification under Chapter 9, Section 5 of the Finnish Securities Markets Act, according to which the holding of Caverion Corporation by Fennogens Investments S.A. based in Luxembourg has increased above the thresholds of 5 and 10 per cent on 28 November 2019. According to the notification,

Caverion Corporation - Managers' transactions - Fennogens Investments S.A.

Caverion Corporation Stock exchange release 29 November 2019 at 9.35 a.m. EETCaverion Corporation - Managers' transactions - Fennogens Investments S.A. Person subject to the notification requirement Name: Fennogens Investments S.A. Position: Closely associated person (X) Legal person (1):Person Discharging Managerial Responsibilities In Issuer Name: Ehrnrooth, Markus Position: Member of the Board Issuer: Caverion Oyj LEI: 7437007ECQWVPCJIS695 Notification type: INITIAL NOTIFICATION Reference number: 7437007ECQWVPCJIS695_20191128184519_4 ___________________

Alligator Bioscience AB appoints Chief Operating Officer

Lund, November 29, 2019 – Alligator Bioscience (Nasdaq Stockholm: ATORX today announced that the company has appointed Dr Malin Carlsson as Chief Operating Officer. She most recently comes from a position as Vice President, Head of Translational Medicine at Ferring Pharmaceuticals in Copenhagen. In Alligator’s management team, Malin Carlsson will have overall responsibility for the company's clinical projects, with emphasis on the development plans for the candidate drugs mitazalimab (ADC-1013) and ATOR-1015, both of which are planned to start phase II clinical studies in 2020. “I am

Caverion Corporation - Managers' transactions - Structor S.A.

Caverion Corporation Stock exchange release 29 November 2019 at 9.30 a.m. EETCaverion Corporation - Managers' transactions - Structor S.A. Person subject to the notification requirement Name: Structor S.A. Position: Closely associated person (X) Legal person (1):Person Discharging Managerial Responsibilities In Issuer Name: Ehrnrooth, Markus Position: Member of the Board Issuer: Caverion Oyj LEI: 7437007ECQWVPCJIS695 Notification type: INITIAL NOTIFICATION Reference number: 7437007ECQWVPCJIS695_20191128184533_5 ____________________________________________

Notification according to Chapter 9, Section 10 of the Finnish Securities Markets Act of change in holdings in Caverion Corporation shares: Structor S.A.

Caverion Corporation Stock exchange release 29 November 2019 at 9.30 a.m. EETNotification according to Chapter 9, Section 10 of the Finnish Securities Markets Act of change in holdings in Caverion Corporation shares: Structor S.A.  Caverion Corporation has on 28 November 2019 received a notification under Chapter 9, Section 5 of the Finnish Securities Markets Act, according to which the holding in Caverion Corporation by Structor S.A., a company 100% owned by Fennogens Investments S.A. based in Luxembourg, has decreased below the thresholds of 10 and 5 per cent on 28 November 2019.

Interim Report Third Quarter 2019

FluoGuide A/S ("FluoGuide") today announces its results for the period 01/July/2019 – 30/Sep/2019. The full report is available on the company’s homepage.Morten Albrechtsen, CEO of FluoGuide, comments: “We are very pleased that the supply chain for FG001 has been established to support the first clinical study in humans and the process for FG001 manufacturing was successfully transferred to vendors who can make it to a quality needed for human use. This is good news and a major de-risking for a positive proof-of-concept clinical result in patients with glioblastoma undergoing surgery. Also,

Change of number of shares and votes in Rejlers

As previously announced, Rejlers AB (publ) (“Rejlers”) has carried out a directed issue of 1,600,000 shares of series B to qualified investors at a subscription price of SEK 96.40 per share (for further information, see Rejlers’ press releases on 24 and 25 October 2019). As a result thereof, the number of shares and votes in Rejlers has changed. The number of shares in Rejlers today, the last trading day of the month, amounts to 19,687,909 shares, whereof 1,749,250 shares of series A and 17,938,659 shares of series B. The total number of votes in Rejlers amounts to 35,431,159.

Number of shares and votes in EQT

The number of shares and votes in EQT AB (publ) (“EQT AB”) has changed as a result of the issue of class C shares resolved upon by the board of directors on 13 November 2019 on the basis of an authorization from the annual general meeting on 27 June 2019. The share issue forms part of the EQT Share Program resolved upon by the annual general meeting. EQT AB holds all class C shares. The class C shares will be delivered to qualifying participants in the program and converted into ordinary shares at the end of the holding period in accordance with the terms and conditions of the EQT Share

Reclassification of series B shares in Moberg Pharma AB (publ)

STOCKHOLM, November 29[th], 2019. During November 2019, Moberg Pharma AB (publ) (“Moberg Pharma” or the “Company”) has, in accordance with the conversion clause in the Company’s articles of association, reclassified 660,843 series B shares into the same number of ordinary shares. The reclassification entails an increase in the number of ordinary shares and a decrease in the number of series B shares, but does not affect the total number of shares or votes in the Company.Before the reclassification, the total number of shares in Moberg Pharma amounted to 18,853,510, of which 18,192,667 were

Safeture AB (publ) publishes interim report for third (3) quarter 2019

Summary of interim Report “Parent company” or “Safeture”, comprises of Safeture AB with company number 556776-4674, without subsidiaries. “The Group” comprises the Parent company, including subsidiaries. On September 30, 2019, the Parent company owned 100% of the shares in GWS Production (Singapore) Pte Ltd, 99,99% of the shares in GWS do Brasil Solucões e Sistemas Tecnológicos em Seguranca Ltda and 35% of the shares in Carefindy AB (minority interest). THE GROUP First nine months (2019-01-01 to 2019-09-30) · Net turnover amounted to 16 132 (13 445) TSEK, an increase of 20,0%

Sectra’s six-month interim report 2019/2020: Imaging IT Solutions’ order bookings exceed SEK 2 billion on a rolling 12-month basis

Press release – Linköping, November 29, 2019 – Demand for the international medical imaging IT and cybersecurity company Sectra’s  (STO: SECT B) products increased and record-high order bookings were reported for the most recent 12-month period. A significant number of the orders pertain to long-term projects with new customers. In line with what has been previously stated, these projects had a negative impact on cash flow and earnings during the first half of 2019/2020. The projects’ earnings and cash flows will improve as the systems are gradually put into

InCoax Networks AB’s Interim Report, January–September 2019

During the third quarter, additional evaluation studies started and the first reference customers are in place. 26 potential customers are in test phase and commercial discussion are underway. Ongoing work with five major operators is providing exciting opportunities in the short and medium term.Financial performance July–September 2019 · Net sales amounted to SEK 178,947 (408,972), which is equivalent to a decrease of 56% compared with the corresponding period in the preceding year. · The company posted an operating loss of SEK –13,624,785 (–11,347,662), a reduction driven

Date for 2020 AGM and Nomination Committee of Sectra AB

Linköping, Sweden, November 29, 2019 – The international medical imaging IT and cybersecurity company Sectra  (STO: SECT B) has decided that the company’s Annual General Meeting (AGM) will be held on September 8, 2020 in Linköping, Sweden. A Nomination Committee has been appointed in accordance with the resolution of the AGM 2019.Sectra has appointed a Nomination Committee comprising four members, one of whom is the Chairman of the Board and three of whom represent the largest shareholders in the company based on the number of votes. The Nomination Committee was

LIQUIDITY PROVIDING AGREEMENT

Faron Pharmaceuticals Oy LIQUIDITY PROVIDING AGREEMENT Appointment of Lago Kapital as Liquidity Provider Company announcement, Turku, 29 November 2019 at 9.01 AM (EET)Inside information TURKU - FINLAND- Faron Pharmaceuticals Oy (AIM: FARN) ("Faron" or the "Company"), the clinical stage biopharmaceutical company, announces that it has entered into a liquidity providing agreement (the "LP Agreement") with Lago Kapital Ltd ("Lago Kapital"). Under the LP Agreement, Lago Kapital will quote bids and offers for the Company's share within the framework for the Nasdaq First North

Interim report for the period 1 January – 30 September 2019

EWPG Holding AB (publ) reports significant progress during the first three quarters of 2019 In Q3, EWPG Holding AB (publ) (the “Company”, “Eco Wave Power” or “EWP”) has been focused on the strengthening of our technology, patent portfolio and expanding our core team and projects pipeline, allowing us to address the global interest for our technology, accelerate the execution of wave energy licensing processes, and strengthen our implementation capacity.Comments to the financials Numbers in parentheses refers to outcomes during the corresponding period of the previous year. Third

GomSpace (provider of nanosatellites) announces its quarterly results for the third quarter 2019

GomSpace Group AB (the “Company”) announces its interim report for the third quarter of 2019. The report is available on the Company’s homepage (www.gomspace.com). The following is taken from the quarterly report:  Third quarter summary 1 July – 30 September 2019 (2018) · Order intake decreased to T.SEK 26,500 (56,469), a decrease of 53% · Net revenues decreased to T.SEK 15,765 (33,608), a decrease of 53% · Gross margin decreased to 11% (34%) · Operating profit (loss) increased to a negative T.SEK 27,270 (a negative 30,357) · Earnings per share were a negative SEK 0.

There are no items matching the current filter
There are no more items matching the current filter
Back to top